A new target for gene therapeutics: telomerase.
Nielsen
P E
PE
D001709:Biotechnology; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D066298:In Vitro Techniques; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000494:pharmacology; D019098:Telomerase / Q000037:antagonists & inhibitors* / Q000235:genetics*
D016376:Oligonucleotides, Antisense; D019098:Telomerase